Document ID: chunk:federal_register_of_legislation:F2018L01321:clause:2_314
Version: federal_register_of_legislation:F2018L01321
Segment Type: clause
Provision Reference: sch 2 cl 314
Character Range: 40548–44328

314                                                                                                An application involving the cancellation of an existing approval that was granted:                                                                                                                                                                                                                                                                       The proposed premises are in the same town as the existing premises
                                                                                                   (a) following an application of a kind mentioned in item 131 or 132 of Part 2 of Schedule 1; or
                                                                                                   (b) following an application of the kind mentioned in item 114 of Part 2 of Schedule 1 to the National Health (Australian Community Pharmacy Authority Rules) Determination 2006 (No. PB 23 of 2006); or
                                                                                                   (c) following a recommendation by the Authority:
                                                                                                   (i) under paragraph 5(b) of the Pharmaceutical Benefits Determination under subsection 99L (1) (No. PB 8 of 2000); or
                                                                                                   (ii) under paragraph 5(b) of the Pharmaceutical Benefits Determination under subsection 99L (1) (No. PB 8 of 2006); or
                                                                                                   (d) following an application of a kind mentioned in Part 1 of Schedule 1 that involved the cancellation of an existing approval that was granted in a circumstance mentioned in paragraph (a), (b) or (c) of this item; or
                                                                                                   (e) following an application of a kind mentioned in Part 1 of Schedule 1 to the National Health (Australian Community Pharmacy Authority Rules) Determination 2006 (No. PB 23 of 2006) that involved the cancellation of an existing approval that was granted in a circumstance mentioned in paragraph (b) or (c) of this item; or
                                                                                                   (f) following a recommendation by the Authority under paragraph 6 or 7, and in accordance with paragraph 9, of the Pharmaceutical Benefits Determination under subsection 99L (1) (No. PB 8 of 2006) that involved the cancellation of an existing approval that was granted in a circumstance mentioned in subparagraph (c)(i) or (ii) of this item; or
                                                                                                   (g) following a recommendation by the Authority under paragraph 6 or 7, and in accordance with paragraph 9, of the Pharmaceutical Benefits Determination under subsection 99L (1) (No. PB 8 of 2000) that involved the cancellation of an existing approval that was granted in the circumstance mentioned in subparagraph (c)(ii) of this item; or
                                                                                                   (h) following an application:
                                                                                                   (i) that was of a kind mentioned in subsection 90(3AA) or (3AE) of the Act; and
                                                                                                   (ii) that involved the cancellation of an approval that was granted in a circumstance mentioned in paragraph (a), (b), (c), (d), (e), (f) or (g) of this item